Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00436
|
|||||
| Drug Name |
Metoprolol
|
|||||
| Synonyms |
(RS)-Metoprolol; 1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol; 1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol; 1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol; 1-[(1-methylethyl)amino]-3-({4-[2-(methyloxy)ethyl]phenyl}oxy)propan-2-ol; 1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol; 1-[4-(2-methoxyethyl)phenoxy]-3-propan-2-ylamino-propan-2-ol; 3-[4-(2-methoxyethyl)phenoxy]-1-(propan-2-ylamino)propan-2-ol; AstraZeneca Brand of Metaoprolol Tartrate; AstraZeneca Brand of Seloken; Beatrolol; Beloc Duriles; Beloc-Duriles; BelocDuriles; Betaloc; Betaloc (TN); Betaloc Astra; Betaloc-Astra; BetalocAstra; Betalok; CGP 2175; CGP-2175; CGP2175; Corvitol (TN); Dl-Metoprolol; Dutoprol; H 93 26; H 93-26; H 9326; LOPRESSIDONE; Leiras Brand of Metoprolol Succinate or Metoprolol Tartrate; Lopresor; Lopresoretic; Lopressor; Lopressor (TN); Meijoprolol; Metohexal; Metoprolol (USAN/INN); Metoprolol [USAN:INN:BAN]; Metoprolol succinate; Metoprololum; Metoprololum [INN-Latin]; Metrol (TN); Metroprolol; Minax (TN); Neobloc (TN); Novartis Brand of Metprolol Tartrate; Preblok; Presolol; Selo-Zok; Selokeen (TN); Seloken; Seloken AstraZeneca Brand; Seroken; Spesicor; Spesikor; TOPROL-XL; Tartrate, Metoprolol; Toprol; Toprol-XL (TN)
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Angina [ICD11: BA40] | Approved | [1] | |||
| High blood pressure [ICD11: BA00] | Approved | [1] | ||||
| Therapeutic Class |
Antihypertensive Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C15H25NO3
|
|||||
| Canonical SMILES |
CC(C)NCC(COC1=CC=C(C=C1)CCOC)O
|
|||||
| InChI |
InChI=1S/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3
|
|||||
| InChIKey |
IUBSYMUCCVWXPE-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 37350-58-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 267.36 | Topological Polar Surface Area | 50.7 | ||
| Heavy Atom Count | 19 | Rotatable Bond Count | 9 | |||
| Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
1.9
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103164420
, 104179199
, 104305635
, 10520685
, 11533336
, 117664446
, 124749948
, 124886734
, 125349182
, 126443769
, 126524234
, 126628938
, 126639359
, 126654065
, 126670412
, 126687042
, 126732563
, 128220647
, 131312492
, 131472906
, 132210550
, 134337774
, 135144539
, 14799183
, 29223277
, 46506211
, 48416268
, 4904669
, 49698871
, 50023420
, 50103878
, 50103879
, 50103880
, 53790219
, 56310948
, 56313025
, 56413044
, 57322176
, 7849417
, 78524559
, 7979976
, 81040953
, 8152611
, 85209393
, 85789202
, 92309031
, 92717148
, 93619457
, 9411
, 99234266
|
|||||
| ChEBI ID |
ChEBI:6904
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | PEPT1 | Transporter Info | Peptide transporter 1 | Substrate | [2] | |
| References | ||||||
| 1 | Metoprolol was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Peptide transporter substrate identification during permeability screening in drug discovery: comparison of transfected MDCK-hPepT1 cells to Caco-2 cells. Arch Pharm Res. 2007 Apr;30(4):507-18. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.